Registration was successful!
Please follow the link from the email sent to

Results of Studies of 3rd Russian Vaccine Against COVID-19 Expected by Mid-December

© Sputnik / Alexei Danichev / Go to the photo bankA health worker holds the Russian coronavirus vaccine Gam-COVID-Vac, trade-named Sputnik V, developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during the vaccination of medical workers, in Sestroretsk, Leningrad region, Russia
A health worker holds the Russian coronavirus vaccine Gam-COVID-Vac, trade-named Sputnik V, developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during the vaccination of medical workers, in Sestroretsk, Leningrad region, Russia - Sputnik International
Subscribe
MOSCOW (Sputnik) - Results of studies on the third domestic vaccine against the coronavirus infection are expected by mid-December, Russian Health Minister Mikhail Murashko said on Thursday.

"The third vaccine, research is currently underway on it, and we expect results on it by mid-December," Murashko told the Rossiya 1 broadcaster.

He clarified that lists of those categories of people that should be vaccinated were being formed now.

On Wednesday, Russian President Vladimir Putin stated that the country's second vaccine against COVID-19, dubbed "EpiVacCorona", was officially registered by the "Vector" centre.

Russian Minister of Industry and Trade Denis Manturov at a Federation Council meeting - Sputnik International
'No Adverse Effects': Russian Minister on Why He Chose COVID Vaccine Based on Human Adenovirus
He added that a third Russian coronavirus vaccine, developed by the Chumakov Centre, would also be registered in the near future.

In August, Russia became the first country in the world to register a vaccine against COVID-19, dubbed Sputnik V and developed by the Gamaleya research institute. Gamaleya's drug requires two injections, using different adenoviral vectors, in order to form immunity from the coronavirus that can last up to two years.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала